Onn A - Search Results

1

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS. Onn A, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43. doi: 10.1158/1078-0432.ccr-0373-3. Clin Cancer Res. 2004. PMID: 14734462

2

Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.

Onn A, Tseng JE, Herbst RS. Onn A, et al. Clin Cancer Res. 2001 Nov;7(11):3311-3. Clin Cancer Res. 2001. PMID: 11705841 No abstract available.

3

Angiogenesis, metastasis, and lung cancer. An overview.

Onn A, Herbst RS. Onn A, et al. Methods Mol Med. 2003;74:329-48. doi: 10.1385/1-59259-323-2:329. Methods Mol Med. 2003. PMID: 12415706 Review. No abstract available.

4

Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxin.

Fan D, Yano S, Shinohara H, Solorzano C, Van Arsdall M, Bucana CD, Pathak S, Kruzel E, Herbst RS, Onn A, Roach JS, Onda M, Wang QC, Pastan I, Fidler IJ. Fan D, et al. Among authors: onn a. Mol Cancer Ther. 2002 Jun;1(8):595-600. Mol Cancer Ther. 2002. PMID: 12479219

5

Metastatic potential of human neoplasms.

Onn A, Fidler IJ. Onn A, et al. In Vivo. 2002 Nov-Dec;16(6):423-9. In Vivo. 2002. PMID: 12494885 Review.

6

The role of growth factor signaling in malignancy.

Herbst RS, Onn A, Mendelsohn J. Herbst RS, et al. Among authors: onn a. Cancer Treat Res. 2003;115:19-72. doi: 10.1007/0-306-48158-8_2. Cancer Treat Res. 2003. PMID: 12613192 Review. No abstract available.

7

New targets for the treatment of advanced non-small cell lung cancer.

Massarelli E, Onn A, Zinner R, Khuri FR, Kim ES, Herbst RS. Massarelli E, et al. Among authors: onn a. Cancer Chemother Biol Response Modif. 2002;20:717-61. Cancer Chemother Biol Response Modif. 2002. PMID: 12703232 Review. No abstract available.

8

Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS. Onn A, et al. Clin Cancer Res. 2003 Nov 15;9(15):5532-9. Clin Cancer Res. 2003. PMID: 14654533

9

Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.

McGary EC, Onn A, Mills L, Heimberger A, Eton O, Thomas GW, Shtivelband M, Bar-Eli M. McGary EC, et al. Among authors: onn a. J Invest Dermatol. 2004 Feb;122(2):400-5. doi: 10.1046/j.0022-202X.2004.22231.x. J Invest Dermatol. 2004. PMID: 15009722 Free article.

10

Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.

Onn A, Tsuboi M, Thatcher N. Onn A, et al. Br J Cancer. 2004 Aug;91 Suppl 2(Suppl 2):S11-7. doi: 10.1038/sj.bjc.6602062. Br J Cancer. 2004. PMID: 15340373 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters